TScan Therapeutics, Inc. (TCRX) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $228.79M | -38.4% |
| 2024 | $371.12M | +36.4% |
| 2023 | $272.15M | +36.7% |
| 2022 | $199.09M | +5.8% |
| 2021 | $188.11M | +278.2% |
| 2020 | $49.74M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $228.79M | -38.4% |
| 2024 | $371.12M | +36.4% |
| 2023 | $272.15M | +36.7% |
| 2022 | $199.09M | +5.8% |
| 2021 | $188.11M | +278.2% |
| 2020 | $49.74M | — |